Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.
MET-EGFR双重联合抑制对抗T790M-EGFR介导的厄洛替尼耐药肺癌
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6604559
Tang Z, Du R, Jiang S, Wu C, Barkauskas D S, Richey J, Molter J, Lam M, Flask C, Gerson S, Dowlati A, Liu L, Lee Z, Halmos B, Wang Y, Kern J A, Ma P C